We studied the effect of high-dose mouse Ige on TMEV-induced demyelinating
disease (TMEV-IDD). We injected TMEV intracerebrally into susceptible SJL/J
mice and induced TMEV-IDD. Mouse IgG were injected intraperitonealy, and c
linical course and various immunological indicators were studied. The resul
ts show that TMEV-IDD was significantly suppressed both clinically and hist
ologically (P<0.01) when IgG were administered in the effector phase. The d
elayed type hypersensitivity and T cell proliferative response specific for
TMEV were decreased by this treatment. In an ELISPOT assay, the number of
TNF-alpha producing lymphocytes in the spinal cords was low in high-dose Ig
G treated mice compared with PBS treated control mice. These data suggest t
hat administration of IgG suppresses TMEV-IDD and may be promising treatmen
t to prevent exacerbation of human multiple sclerosis. (C) 2000 Elsevier Sc
ience B.V. All rights reserved.